{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8312868", "DateCompleted": {"Year": "1994", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0918-6158", "JournalIssue": {"Volume": "16", "Issue": "11", "PubDate": {"Year": "1993", "Month": "Nov"}}, "Title": "Biological & pharmaceutical bulletin", "ISOAbbreviation": "Biol Pharm Bull"}, "ArticleTitle": "Hypoglycemic activity of polygonati rhizoma in normal and diabetic mice.", "Pagination": {"StartPage": "1118", "EndPage": "1120", "MedlinePgn": "1118-20"}, "Abstract": {"AbstractText": ["The hypoglycemic effect of different dose of Polygonati Rhizoma, i.e., \"Ousei\", was investigated in both normal and streptozotocin-induced diabetic mice. The methanol extract of Polygonati Rhizoma (OM) (800 mg/kg) reduced the blood glucose of normal mice from 202 +/- 7 to 144 +/- 13 mg/100 ml 4 h after intraperitoneal administration (p < 0.01), and also lowered significantly the blood glucose of streptozotocin-induced diabetic mice from 589 +/- 34 to 396 +/- 15 mg/100 ml under similar conditions (p < 0.001). However, the hypoglycemic effects were not accompanied by any alteration in the serum insulin in these mice. OM also suppressed epinephrine-induced hyperglycemia in mice. These results support, therefore, the use of Polygonati Rhizoma in patients with diabetes and confirm its role as a traditional medicine. In addition, one of the active components of OM was identified as a spirostanol glycoside (PO-2)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kobe Women's College of Pharmacy, Hyogo, Japan."}], "LastName": "Kato", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Miura", "ForeName": "T", "Initials": "T"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Biol Pharm Bull", "NlmUniqueID": "9311984", "ISSNLinking": "0918-6158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9005-79-2", "NameOfSubstance": "Glycogen"}, {"RegistryNumber": "982XCM1FOI", "NameOfSubstance": "Tolbutamide"}, {"RegistryNumber": "YKH834O4BH", "NameOfSubstance": "Epinephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["analysis"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": [], "DescriptorName": "Epinephrine"}, {"QualifierName": [], "DescriptorName": "Glucose Tolerance Test"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glycogen"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Hyperglycemia"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tolbutamide"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1993", "Month": "11", "Day": "1"}, {"Year": "1993", "Month": "11", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8312868", "10.1248/bpb.16.1118"]}}]}